BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND RARA, RAR, 5914, ENSG00000131759, NR1B1 AND Clinical Outcome
19 results:

  • 1. Co-occurrence of PML-rara gene fusion, chromosome 8 trisomy, and FLT3 ITD mutation in a young female patient with de novo acute myeloid leukemia and early death: A CARE case report.
    Tripon F; Crauciuc GA; Bogliş A; Moldovan V; Sándor-Kéri J; Benedek IJ; Trifa AP; Bănescu C
    Medicine (Baltimore); 2020 Apr; 99(14):e19730. PubMed ID: 32243411
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification of the Adapter Molecule MTSS1 as a Potential Oncogene-Specific Tumor Suppressor in Acute Myeloid leukemia.
    Schemionek M; Kharabi Masouleh B; Klaile Y; Krug U; Hebestreit K; Schubert C; Dugas M; Büchner T; Wörmann B; Hiddemann W; Berdel WE; Brümmendorf TH; Müller-Tidow C; Koschmieder S
    PLoS One; 2015; 10(5):e0125783. PubMed ID: 25996952
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Expression of musashi-2 gene in leukemia stem cells from acute myeloid leukemia patients].
    Ye AF; Han YX; Zhang SH; Li HY; Chen CQ; Wu JB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1235-8. PubMed ID: 25338564
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The drug-induced degradation of oncoproteins: an unexpected Achilles' heel of cancer cells?
    Ablain J; Nasr R; Bazarbachi A; de Thé H
    Cancer Discov; 2011 Jul; 1(2):117-27. PubMed ID: 22586354
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Patient-specific analysis of FLT3 internal tandem duplications for the prognostication and monitoring of acute myeloid leukemia.
    Schiller J; Praulich I; Krings Rocha C; Kreuzer KA
    Eur J Haematol; 2012 Jul; 89(1):53-62. PubMed ID: 22458420
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. clinical significance of the most common chromosome translocations in adult acute myeloid leukemia.
    Mrózek K; Bloomfield CD
    J Natl Cancer Inst Monogr; 2008; (39):52-7. PubMed ID: 18648004
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. CD2+ tetraploid acute promyelocytic leukemia variant with double (15;17) translocations.
    Kaito K; Otsubo H; Dobashi N; Usui N; Kobayashi M
    Int J Hematol; 2005 Jan; 81(1):29-31. PubMed ID: 15717685
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. PML-rara-targeted DNA vaccine induces protective immunity in a mouse model of leukemia.
    Padua RA; Larghero J; Robin M; le Pogam C; Schlageter MH; Muszlak S; Fric J; West R; Rousselot P; Phan TH; Mudde L; Teisserenc H; Carpentier AF; Kogan S; Degos L; Pla M; Bishop JM; Stevenson F; Charron D; Chomienne C
    Nat Med; 2003 Nov; 9(11):1413-7. PubMed ID: 14566333
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Acute promyelocytic leukemia M3: cytomorphologic, immunophenotypic, cytogenetic, and molecular variants.
    Sucić M; Zadro R; Burazer B; Labar B; Nemet D; Mrsić M; Aurer I; Mrsić S; Hitrec V; Boban D; Marković-Glamocak M; Batinić D; Uzarević B; Stavljenić-Rukavina A
    J Hematother Stem Cell Res; 2002 Dec; 11(6):941-50. PubMed ID: 12590709
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Quantitative real-time RT-PCR analysis of PML-rar alpha mRNA in acute promyelocytic leukemia: assessment of prognostic significance in adult patients from intergroup protocol 0129.
    Gallagher RE; Yeap BY; Bi W; Livak KJ; Beaubier N; Rao S; Bloomfield CD; Appelbaum FR; Tallman MS; Slack JL; Willman CL
    Blood; 2003 Apr; 101(7):2521-8. PubMed ID: 12468436
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Not the presence but the amount of clonal DNA detectable in remission of acute myeloid leukemia is predictive for relapse.
    Reif SW; Wiesner D; Duell T; Mittermueller J; Schmetzer HM
    Eur J Haematol; 2001 Oct; 67(4):207-20. PubMed ID: 11860441
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Combination of all-trans retinoic acid with butyric acid and its prodrugs markedly enhancing differentiation of human acute promyelocytic leukemia NB4 cells.
    Chen Z; Wang W; Pan J; Chen L; Xue Y
    Chin Med J (Engl); 1999 Apr; 112(4):352-5. PubMed ID: 11593538
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-rar alpha isoforms: a study of the PETHEMA group.
    González M; Barragán E; Bolufer P; Chillón C; Colomer D; Borstein R; Calasanz MJ; Gómez-Casares MT; Villegas A; Marugán I; Román J; Martín G; Rayón C; Debén G; Tormo M; Díaz-Mediavilla J; Esteve J; González-San Miguel J; Rivas C; Pérez-Equiza K; García-Sanz R; Capote FJ; Ribera JM; Arias J; León A; Sanz MA;
    Br J Haematol; 2001 Jul; 114(1):99-103. PubMed ID: 11472351
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The PML-rar alpha transcript in long-term follow-up of acute promyelocytic leukemia patients.
    Gameiro P; Vieira S; Carrara P; Silva AL; Diamond J; Botelho de Sousa A; Mehta AB; Prentice HG; Guimarães JE; Hoffbrand AV; Foroni L; Parreira A
    Haematologica; 2001 Jun; 86(6):577-85. PubMed ID: 11418366
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy.
    Ferrara F; Morabito F; Martino B; Specchia G; Liso V; Nobile F; Boccuni P; Di Noto R; Pane F; Annunziata M; Schiavone EM; De Simone M; Guglielmi C; Del Vecchio L; Lo Coco F
    J Clin Oncol; 2000 Mar; 18(6):1295-300. PubMed ID: 10715300
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Molecular analysis and clinical outcome of adult APL patients with the type V PML-raralpha isoform: results from intergroup protocol 0129.
    Slack JL; Willman CL; Andersen JW; Li YP; Viswanatha DS; Bloomfield CD; Tallman MS; Gallagher RE
    Blood; 2000 Jan; 95(2):398-403. PubMed ID: 10627441
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Association of PML-rar alpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular study.
    Gallagher RE; Willman CL; Slack JL; Andersen JW; Li YP; Viswanatha D; Bloomfield CD; Appelbaum FR; Schiffer CA; Tallman MS; Wiernik PH
    Blood; 1997 Aug; 90(4):1656-63. PubMed ID: 9269786
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. rar alpha1/rar alpha2-PML mRNA expression in acute promyelocytic leukemia cells: a molecular and laboratory-clinical correlative study.
    Li YP; Andersen J; Zelent A; Rao S; Paietta E; Tallman MS; Wiernik PH; Gallagher RE
    Blood; 1997 Jul; 90(1):306-12. PubMed ID: 9207466
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. PML-rar alpha fusion transcripts by RNA PCR in acute promyelocytic leukemia in remission and its correlation with clinical outcome.
    Ikeda K; Sasaki K; Tasaka T; Nagai M; Kawanishi K; Takahara J; Irino S
    Int J Hematol; 1994 Oct; 60(3):197-205. PubMed ID: 7858239
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.